Symbiota®, microbiome products, exclusively developed by Microbio Co., Ltd.

Symbiota® are microbiome-based products successfully developed by Microbio’s proprietary symbiotic anaerobic fermentation technology using multi-strain probiotics. Symbiota® products comprise metabolic essence (metabolites) generated by the symbiotic fermentation of intestinal probiotics, which are the “Postbiotics” products meticulously developed by the most cutting-edge technology.

Approved for use in a variety of effective products

Symbiota are the gut microbiome based products successfully developed by Microbio’s proprietary symbiotic anaerobic fermentation technology using multi-strain probiotics, which are the cutting-edge “postbiotics” comprises the metabolites from symbiotic fermentation of gut probiotics. MS-20, the first approved new drug as an oral adjuvant therapy for chemotherapy in Taiwan, PrimeEnzyme available in Cotton-Field Organic, Microsoy, Young, TB90010 that is a newly-developed microbiome based product for type2 diabetes management, and LT17 for alleviating liver function are all developed by Symbiota technology with different bacterial strains.

Metabolites from symbiotic fermentation of gut probiotics, the postbiotics of multi-strain probiotics.

The achievement of U.S. Independent / Self-affirmed GRAS conclusion for Symbiota is a key market entry strategy of the company. Unlike probiotics, this GRAS conclusion is the first on the postbiotics derived from symbiotic fermentation of multi-strain probiotics in Taiwan, and the GRAS determination includes the soybean fermentates generated by multi-strain probiotics and yeasts or mixtures of these strains, which covers all current Microbio’s proprietary microbiome-based portfolio. Multiple patents protection cover Symbiota product, technology, and use have been granted by major countries in the world. Symbiota according to the regulations of different countries will adopt a diverse regulatory strategies, including new drug, medical device, medical food, dietary supplement, and regular food to accelerate the global market entry.

Various functional products are coming as a variety of food categories covered in GRAS 

According to the GRAS conclusion, Symbiota® can be used in nutritional beverages, protein and nutritional powder, smoothies, and grain drinks, regular and diet sports and energy drinks, regular and diet soft drinks, fruit drinks including unreconstituted powders, dairy drinks, and milk substitutes, gelatin-type candies, ready to eat cereals, and cooked cereals at usage levels up to 20% for the liquid form and 10% for the powdered form for the people from 1 to 110 years.

“Tien Chun Bao” Prime Enzyme

Brand new formula “Tien Chun Bao” Prime Enzyme which contains a key raw material, Microbio’s microbiome-based Symbiota® covered by multi-national patents, can help with microbiome modulation to support digestive functions and improve constipation. This product is not only suitable for different populations and can provide multifaceted benefits. For stressful office workers or students, Prime Enzyme can help with maintaining energized and healthy status. Housewife can consume it to keep youth and beauty and to obtain nutritional supplementation. For seniors or for patients recovering after surgery, it can help with physical adjustment and promote metabolic activities. No matter what stage of life you are in, “Tien Chun Bao” Prime Enzyme will provide comprehensive supports for your needs.

Chemo young (MS-20)

Microbio spent 14 years and invested more than NT$1 billion in the research and development of “Chemo young” oral solution. It is a new oral cancer drug developed in accordance with international new drug development standards, and it was approved for use as an adjuvant therapy new drug for cancer in Taiwan. It can effectively improve the fatigue and loss of appetite caused by chemotherapy and improve the ability of cancer patients to maintain family and social activities. Its clinical efficacy is evident. Due to its good safety, Taiwan FDA approved it as an OTC drug for sale. It can be sold in hospitals, clinics, pharmacies and other places where Chinese or Western doctors or pharmacists are stationed. It is not constricted to doctor’s prescription, which is a great boon for cancer patients. The company-initiated clinical trial of MS-20 in combination with Pembrolizumab (anti-PD1 therapy) for the treatment of metastatic non-small cell lung cancer (NSCLC) is currently ongoing. Obtaining the GRAS conclusion will facilitate the product launch to global markets following the completion of the trial.

Microsoy

A health solution based on centuries of fermentation experience, combined with traditional wisdom and modern technology provides optimal nutrients for indigenous probiotics in the gastrointestinal tract. It also obtains three national certificates for healthy product, including gastrointestinal function improvement, blood lipid modulation, and immune regulation, and is the best choice of health care for whole family.

Young

Young that is crafted with a sophisticated process of lactic acid bacteria fermentation and nanotechnology not only can rapidly facilitate the increase of gut probiotics to help with maintaining digestive functions, but it can also promote the amplification of splenocytes and the activity of nature killer cells, which can effectively modulate immune functions. It is an ultimate health care product that is able to awaken the body’s native power.